Professor Danny Altmann
Danny is Professor of Immunology at Imperial College London, where he heads a lab.. During the pandemic he has advised policymakers including the House of Commons and House of Lords Science Committees, the APPG on Coronavirus, the Cabinet Office, Sir Keir Starmer and the Shadow Cabinet, the Welsh Assembly, the EU, The Scottish Parliament, WHO, NICE and the Department of Health. For over 20 years Danny has edited medical journals including Oxford Open Immunology, Immunology, and Vaccine. He is a trustee at the Medical Research Foundation and a board member for the African Research Excellence Fund. He previously headed strategy on infection, immunity and population health at the Wellcome Trust. His research interests focus on the immunology of infectious diseases including severe bacterial infections, SARS-CoV-2, Zika virus and Chikungunya virus. He also has a long record in autoimmunity research. Danny’s SARS-CoV-2 research is published in journals including the Lancet, Nature and Science. He heads an NIHR-funded research programme to look at mechanisms of pathogenesis and development of new diagnostic tests in a large cohort of individuals with Long Covid.
External website: https://www.imperial.ac.uk/people/d.altmann